The rapid expansion of monoclonal antibody manufacturing, increasing demand for biologics contract manufacturing organization services, and the growing need for antibody production services are transforming the global biopharmaceutical industry. As pharmaceutical and biotechnology companies continue to develop innovative biologics for oncology, autoimmune disorders,...

Technological advancements are the primary engine of progress in the Biosimilar Contract Manufacturing Market. Recent breakthroughs in perfusion bioreactors and automated cell culture monitoring have allowed manufacturers to achieve higher yields and consistent product quality. These technologies are not only reducing the operational costs of biologics but also making it possible to produce...

China IVD CMO competitive landscape — the diverse ecosystem of contract manufacturers ranging from large integrated diagnostic manufacturers offering CMO services to specialized pure-play CMOs — creates the competitive structure of China's IVD contract manufacturing market, with the China IVD Contract Manufacturing Market reflecting market structure as an important commercial...

The global fill-finish pharmaceutical contract manufacturing market was valued at USD 18.0 billion in 2024 and is projected to reach USD 29.1 billion by 2030, expanding at a CAGR of 8.3% from 2025 to 2030. The market is expected to increase from USD 21.1 billion in 2026. North America represented the largest regional market in 2024, accounting for 34.9% of global revenue. A major factor...

The global food contract manufacturing market is expanding as food brands, retailers, and emerging food businesses increasingly outsource production to specialized manufacturers. This business model enables companies to introduce new products, improve production efficiency, and expand their market presence without investing heavily in manufacturing facilities and equipment. Contract...

Future Outlook of the Medical Device Contract Manufacturing Market: Opportunities and Industry Forecast Market Overview and Growth Snapshot The future of the Medical Device Contract Manufacturing Market looks promising due to increasing demand for medical technologies and the growing complexity of medical device production. The growing complexity of medical devices, along with strict regulatory...

The Antibody Contract Manufacturing Market is witnessing significant transformation, shaped by innovation, evolving consumer expectations, regulatory shifts, and global economic trends. Polaris Market Research’s latest report, Antibody Contract Manufacturing Market, offers a holistic view of the market. It examines the market’s structure, growth drivers, competitive landscape, and...

According to a new report from Intel Market Research, the global Electronics Contract Manufacturing Services market was valued at USD 78.4 billion in 2025 and is projected to reach USD 115.6 billion by 2034, exhibiting a robust CAGR of 4.1% during the forecast period (2025–2034). This growth is precipitated by the accelerating demand for consumer Internet‑of‑Things (IoT) devices,...

The Healthcare Contract Manufacturing Market is witnessing significant transformation, shaped by innovation, evolving consumer expectations, regulatory shifts, and global economic trends. Polaris Market Research’s latest report, Healthcare Contract Manufacturing Market, offers a holistic view of the market. It examines the market’s structure, growth drivers, competitive landscape,...

The medical device contract manufacturing sector plays a significant role in supporting modern healthcare product development by providing end-to-end manufacturing, assembly, and packaging services for device makers of all sizes. Contract manufacturers are increasingly incorporating automation and precision-engineering technologies that improve production quality and scalability. The growing...

The global Healthcare Contract Manufacturing Market is witnessing robust growth, driven by increasing demand for cost-effective production, technological advancements, and a rapidly aging population. According to the latest market analysis, the market size was valued at USD 251.19 Billion in 2025 and is projected to grow at a CAGR of 7.5% from 2026 to 2032, reaching...

The global softgel capsules market was valued at USD 8.5 billion in 2025 and is expected to reach USD 9.1 billion in 2026, before expanding to USD 15.4 billion by 2033. This represents a 7.9% CAGR from 2026 to 2033. North America led the market in 2025 with a 41.2% global revenue share, while Asia Pacific is expected to register the fastest growth during the forecast period. Market Snapshot...

The Biopharmaceuticals Contract Manufacturing Market is expanding as pharmaceutical and biotechnology companies increasingly outsource complex biologics manufacturing to specialized contract development and manufacturing organizations. The market was valued at USD 44.7 billion in 2025 and is projected to grow from USD 50.0 billion in 2026 to USD 100.8 billion by 2033, registering a CAGR of...

The medical device contract manufacturing market is entering a period of strong expansion as medical device companies increasingly rely on specialized manufacturing partners to improve cost efficiency, manage regulatory complexity, accelerate product development, and scale production. Download a free sample copy of the Medical Device Contract Manufacturing market report to understand detailed...

European IVD contract manufacturing — the established CMO ecosystem in Denmark, Netherlands, Germany, UK, and Ireland providing high-quality IVD manufacturing with strong regulatory compliance and deep application expertise — creates the premium tier of global IVD contract manufacturing, with the IVD Contract Manufacturing Market reflecting European CMO quality positioning as a...

The global industry was valued at US$ 2.2 Bn in 2022 and is projected to grow at a CAGR of 7.7% from 2023 to 2031, reaching more than US$ 4.3 Bn by the end of 2031. The nanoparticle contract manufacturing market is witnessing significant growth as pharmaceutical, biotechnology, and life sciences companies increasingly outsource the production of complex nanoparticle-based formulations. Rising...

The global oral solid dosage contract manufacturing market is becoming an increasingly important part of the pharmaceutical manufacturing ecosystem as drug developers and pharmaceutical companies turn to specialized contract development and manufacturing organizations (CDMOs) for formulation development, scale-up, and commercial production. Rising outsourcing activity, growing generic drug...

The global pharmaceutical contract development and manufacturing organization (CDMO) market is witnessing substantial growth, driven by the increasing outsourcing of drug development and manufacturing processes by pharmaceutical companies. As the complexity of drug development rises and cost pressures intensify, CDMOs are becoming essential partners in accelerating time-to-market and improving...